Deal Ends Today·Save 35% annual plan
Anticoagulant (DOAC)Reviewed for 2026 plan year

Does UnitedHealthcare Cover Xarelto?

The verdict

Covered on most plans

Yes — UnitedHealthcare covers Xarelto for atrial fibrillation, VTE, and cardiovascular risk reduction across commercial, ACA, Medicare Advantage/Part D, and Medicaid via its OptumRx PBM, typically as a Tier 3 brand with quantity limits. The 2026 IRA Maximum Fair Price of $197/month applies to Medicare, and the $2,100 annual out-of-pocket cap limits total exposure. Prior authorization is not typical; step therapy is uncommon.

MedicareCovered
CommercialCovered
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
UnitedHealthcare drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice

Key facts

  • Xarelto's 2026 IRA Maximum Fair Price is $197/30-day supply — a 62% reduction from the $517 list price, mandatory for all Medicare Part D plans including UnitedHealthcare.

    CMS. Medicare Drug Price Negotiation Program — Initial Price Applicability Year 2026.

  • The 2026 Medicare Part D out-of-pocket cap is $2,100 — once reached, all Part D drugs cost $0 for the rest of the year.

    CMS Final CY 2026 Part D Redesign Program Instructions.

  • OptumRx is UnitedHealthcare's pharmacy benefit manager — Xarelto's tier placement and quantity limits are governed by the OptumRx formulary for your specific plan.

    UnitedHealthcare/OptumRx member formulary documentation.

Plan types

Medicare vs. commercial coverage

Whether UnitedHealthcare covers Xarelto depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Covered

Covered on UnitedHealthcare's Medicare Advantage/Part D plans (Advantage 3-Tier PDL) as a Tier 3 brand with common quantity limits. The IRA Maximum Fair Price of $197/30-day supply (62% off the $517 list price) applies effective January 1, 2026. OptumRx manages the Part D formulary; Xarelto is on-formulary with PA/step therapy uncommon for a DOAC. The 2026 $2,100 out-of-pocket cap is the hard annual ceiling — once reached, Xarelto is $0 for the rest of the year. Note the coinsurance-shift: many UHC Part D plans shifted IRA-negotiated drugs from fixed copays to coinsurance in 2026, which can increase per-fill costs despite the lower negotiated price. Medicare beneficiaries cannot use the Janssen commercial savings card. Verify your plan's tier-3 structure and quantity limits using the OptumRx formulary tool.

Commercial / Employer

Group & marketplace plans

Covered

Covered on UnitedHealthcare commercial/employer plans via OptumRx PDL, typically Tier 3 with quantity limits. OptumRx runs a Step Therapy program for select high-cost drugs, but step therapy is nationally uncommon for Xarelto — it is an anticoagulant, not a diabetes medication subject to metformin-first stepping. The Janssen savings card ($0 for eligible commercially insured patients) may apply to commercial UHC enrollees — not Medicare/Medicaid. ACA/Individual plans covered where UHC offers them. UHC Community Plan Medicaid covers Xarelto; prior authorization may be required per state PDL at $0–$10 cost-share. Verify coverage on your specific OptumRx or UHC plan formulary.

What you'll pay

Your cost, three ways

What Xarelto actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

$500–$650/month retail (pharmacy-variable estimate; no generic Xarelto available as of 2026)

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Tier 3 cost-share via OptumRx; $2,100 annual OOP cap for Medicare — verify exact copay or coinsurance on your UHC/OptumRx plan formulary

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

J&J/Janssen savings card — $0 for eligible commercially insured patients; not available to Medicare or Medicaid beneficiaries. Visit janssencarepath.com or call 1-855-XARELTO.

Reduced copay through the assistance program, where eligible.

IRA 2026 Maximum Fair Price: $197/30-day supply (effective 1/1/2026). MFP is a payer-side ceiling — fixed copay vs. coinsurance on your OptumRx plan determines per-fill amount. $2,100 out-of-pocket cap applies for Medicare 2026. All figures are estimates; verify cost-share on the OptumRx formulary or by calling UHC Member Services.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Look up Xarelto on the OptumRx formulary

    Log in to your UnitedHealthcare member account at myuhc.com or the UHC app. Navigate to 'Find a Drug' or visit the OptumRx formulary at optumrx.com. Search for 'Xarelto' to confirm the tier, quantity limits, and whether your plan uses a fixed copay or coinsurance at Tier 3 in the 2026 plan year.

  2. 2

    Ask your prescriber whether your dose fits the plan's quantity limit

    UHC/OptumRx plans commonly apply quantity limits to Xarelto. Confirm with your cardiologist or prescribing physician that the daily dose and days' supply fall within the limit. If not, your doctor can request a quantity limit exception through UHC's prior authorization process.

  3. 3

    Confirm your plan's copay vs. coinsurance structure for Tier 3

    In 2026, many UHC Part D plans shifted IRA-negotiated drugs from a fixed copay to coinsurance. Call UHC Member Services at the number on your ID card and ask: 'Does my plan charge a fixed copay or percentage coinsurance for Tier 3 drugs?' This is the most important question for predicting your monthly Xarelto cost. Medicare beneficiaries cannot use the Janssen savings card — the $2,100 annual cap is the primary protection.

If it's denied

Options if UnitedHealthcare won't cover Xarelto

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Eliquis (apixaban)

The other leading DOAC for AFib and VTE. Also covered on UHC/OptumRx as a Tier 3 brand. Eliquis has a 2026 IRA MFP of $231 (vs. Xarelto's $197) and the sharpest coinsurance-shift story in stand-alone Part D. Clinical choice between Eliquis and Xarelto is a decision for your physician.

Warfarin (generic coumadin)

An older anticoagulant available as a low-cost Tier 1 generic on OptumRx formularies. Requires regular INR monitoring and dietary management. Discuss with your physician if cost is a primary concern.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

Yes — UnitedHealthcare covers Xarelto for its FDA-approved indications (atrial fibrillation, DVT, PE, and CAD/PAD cardiovascular risk reduction) across commercial, ACA, Medicare Advantage/Part D, and Medicaid via OptumRx. It is typically Tier 3 with quantity limits. Step therapy is uncommon for a DOAC anticoagulant. The 2026 IRA Medicare price is $197/month and the $2,100 annual cap applies. Verify your specific plan's drug list.

Your Xarelto cost under UHC depends on whether your OptumRx plan uses a fixed copay or coinsurance at Tier 3. The IRA 2026 Maximum Fair Price of $197 is what UHC pays — not necessarily your out-of-pocket. Many UHC Part D plans shifted to coinsurance in 2026 for IRA-negotiated drugs, which may result in higher per-fill costs. The $2,100 annual cap limits total Medicare exposure. Confirm your specific amount on the OptumRx formulary or by calling UHC.

Prior authorization is not typical for Xarelto on UnitedHealthcare Medicare or commercial plans — step therapy is uncommon for a DOAC anticoagulant, unlike SGLT2 inhibitors that often require metformin-first documentation. Quantity limits are standard, however. UHC Community Plan Medicaid may require PA in some states per the state PDL. OptumRx manages the formulary — verify on the OptumRx drug list or call UHC Member Services.

Yes — the 2026 Medicare Part D $2,100 out-of-pocket cap applies to all Part D drugs including Xarelto on UnitedHealthcare Medicare Advantage and stand-alone Part D plans. Once you reach $2,100 in total out-of-pocket Part D costs for the year, Xarelto costs $0 for the remainder of the plan year. This cap applies regardless of whether your plan uses a copay or coinsurance structure at Tier 3.

Only if you have UHC commercial (employer or ACA) insurance. The J&J/Janssen savings card offering $0 cost-share is not available to UnitedHealthcare Medicare Advantage or Medicaid members — it is limited to commercially insured patients. Janssen also retired its 'Xarelto withMe Coverage Gap Support' program because Medicare eliminated the donut hole in 2025. Medicare members should focus on the $2,100 annual cap as their primary cost protection.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.